You are viewing: US Microsampling Devices Market analysis
Part of: Microsampling Devices Market (Global)

The US Microsampling Devices Market was valued at $15.94 Million in 2024 and projected to reach to $23.44 Million by 2029, representing a compound annual growth rate of 8.0%. The US microsampling devices market is positioned for sustained expansion through 2029, driven by increasing demand for patient-centric diagnostic solutions and technological advancements in sampling methodologies.

US Microsampling Devices Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

US Microsampling Devices Market Trends and Insights

  • This 8.0% compound annual growth rate reflects the US healthcare sector's increasing adoption of minimally invasive sampling technologies that reduce patient discomfort and improve diagnostic efficiency.
  • The US market benefits from advanced healthcare infrastructure, strong regulatory frameworks, and rising demand for point-of-care testing solutions across clinical and research settings. Driving this expansion, the US is witnessing heightened investment in personalized medicine and remote patient monitoring capabilities.
  • Healthcare providers across the US are integrating microsampling devices into routine workflows to enhance sample collection quality while reducing biohazard exposure.
  • The forecast period through 2029 indicates sustained momentum as US laboratories and clinical facilities continue modernizing their diagnostic capabilities with these innovative sampling technologies..

Key Market Statistics

  • CAGR (2024-2029) 8.0% CAGR
  • Market Size, 2024 ~USD 15.94 Million
  • Forecast, 2029 ~USD 23.44 Million
  • Country US

US Microsampling Devices Market Overview

Market Valuation :

The US microsampling devices market is valued at $15.94 million in 2024, with strong momentum driven by healthcare provider adoption and patient preference for minimally invasive diagnostic procedures.

Growth Trajectory :

At an 8.0% CAGR through 2029, the US market is outpacing the global average of 7.6%, indicating accelerated domestic adoption and favorable regulatory environment for innovative sampling technologies.

Healthcare Infrastructure :

Advanced US healthcare infrastructure, coupled with high reimbursement rates and strong R&D investment, creates optimal conditions for microsampling device manufacturers and service providers.

Clinical Adoption :

US hospitals, diagnostic labs, and clinical research organizations are increasingly integrating microsampling into routine workflows to reduce patient burden and improve sample quality for accurate diagnostics.

US Microsampling Devices Market Dynamics

  • Healthcare providers are prioritizing minimally invasive approaches to enhance patient experience while maintaining diagnostic accuracy, creating strong demand across hospital systems, outpatient clinics, and research institutions. Regulatory support from the FDA and growing clinical evidence supporting microsampling efficacy will further accelerate market penetration.
  • Investment in point-of-care testing infrastructure and remote patient monitoring capabilities will unlock new applications, particularly in chronic disease management and personalized medicine initiatives across the US healthcare landscape..

Related Ecosystem

Key Takeaways

  • The US microsampling devices market is valued at $15.94 million in 2024 and is expected to reach $23.44 million by 2029, representing an 8.0% CAGR.
  • The US market is driven by adoption of minimally invasive sampling technologies and growing demand for point-of-care testing across US clinical and research facilities.
  • US healthcare providers are increasingly integrating microsampling devices to improve diagnostic efficiency and reduce patient discomfort in routine workflows.
  • Investment in personalized medicine and remote patient monitoring in the US is accelerating market expansion through 2029.

Microsampling Devices Market Report Scope

Report Metric Details
Base Year 2024
Fastest Growing Segment LANCETS (Product)
Forecast Period 2024-2029
Growth Rate CAGR of 7.6% from 2024 to 2029
Largest Segment SINGLE-USE BLOOD COLLECTION DEVICES (Usability)
Market Size Base Year (Billions) ~USD 0.09 (2024)
Revenue Forecast (Billions) ~USD 0.14 (2029)
Segments Covered Product, Sample Type, Collection Method, Device Type, Usability, Application

US Microsampling Devices Market Report Segmentation

6 segment dimensions are covered across the global market.

By Product

  • Dbs Collection Kits
  • Fingerstick Blood Collection Kits
  • Lancets
  • Other Products

By Sample Type

  • Dried Blood Samples
  • Liquid Blood Samples

By Collection Method

  • Fingerstick
  • Other Methods
  • Push-Button

By Device Type

  • Professional Collection Devices
  • Self-Collection Devices

By Usability

  • Reusable Blood Collection Devices
  • Single-Use Blood Collection Devices

By Application

  • Clinical Trials & Research
  • Disease Diagnostics
  • Health Screening & Preventive Health
  • Other Applications

US: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2022–2029

Segment20222023202420252026202720282029CAGR (%)
CLINICAL TRIALS & RESEARCH5.926.046.196.46.677.037.498.075.5
DISEASE DIAGNOSTICS8.859.139.469.8810.411.0711.9112.956.5
HEALTH SCREENING & PREVENTIVE HEALTH14.7715.4316.217.1518.319.7621.5723.828
OTHER APPLICATIONS2.032.062.12.152.232.342.472.654.8
TOTAL31.5732.6533.9435.5837.5940.243.4447.496.9

Target Audience

  • Medical Device Manufacturers : Manufacturers need US-specific market data to develop localized product strategies, understand competitive positioning, and identify gaps in the American microsampling device market for innovation and commercialization.
  • Healthcare Providers & Hospital Systems : Hospital administrators and procurement teams require market insights to evaluate microsampling technology adoption, assess vendor options, and justify capital investments in diagnostic infrastructure upgrades.
  • Diagnostic Laboratory Networks : Lab directors and pathologists need data on US adoption rates, clinical efficacy evidence, and operational benefits to make informed decisions about integrating microsampling into their testing workflows.
  • Investment & Private Equity Firms : Investors evaluating opportunities in US healthcare diagnostics require detailed market sizing, growth projections, and competitive analysis to assess portfolio companies and identify acquisition targets.
  • Clinical Research Organizations : CROs and research institutions need US market intelligence to understand microsampling adoption in clinical trials, patient recruitment strategies, and regulatory requirements for research applications.

Reasons to Buy this Report

  • Market Size & Growth Data : Access precise US market valuation ($15.94M in 2024) and verified forecast projections through 2029, enabling accurate financial planning and investment decisions specific to the American market.
  • Competitive Landscape Intelligence : Understand US-specific market dynamics, key players, and competitive positioning to identify partnership opportunities and market entry strategies tailored to American healthcare regulations and provider preferences.
  • Regulatory & Reimbursement Insights : Gain detailed analysis of FDA approval pathways, insurance coverage policies, and reimbursement trends unique to the US market, critical for product commercialization and revenue forecasting.
  • Clinical Adoption Trends : Discover which US healthcare segments (hospitals, labs, research centers) are leading adoption, enabling targeted marketing strategies and resource allocation for maximum market penetration.
  • Strategic Growth Opportunities : Identify emerging applications in US personalized medicine, remote monitoring, and chronic disease management where microsampling devices can capture new revenue streams and expand market share.

Frequently asked questions

What is the current size of the US microsampling devices market?

The US microsampling devices market was valued at $15.94 million in 2024 and is projected to grow to $23.44 million by 2029.

What is the growth rate of the US microsampling devices market?

The US microsampling devices market is growing at a compound annual growth rate (CAGR) of 8.0% from 2024 to 2029.

What factors are driving growth in the US microsampling devices market?

Key drivers include increased adoption of minimally invasive sampling technologies, rising demand for point-of-care testing, investment in personalized medicine, and expansion of remote patient monitoring capabilities across US healthcare facilities.

Which US healthcare segments are adopting microsampling devices?

US clinical laboratories, research institutions, diagnostic centers, and point-of-care testing facilities are actively integrating microsampling devices into their diagnostic workflows.

How do microsampling devices benefit US healthcare providers?

Microsampling devices reduce patient discomfort, minimize biohazard exposure, improve sample collection quality, and enhance diagnostic efficiency for US healthcare providers.

RESEARCH METHODOLOGY

The objective of the study is to analyze the key market dynamics, such as drivers, opportunities, restraints, challenges, and key player strategies. To track company developments such as acquisitions, product launches, expansions, agreements, and partnerships of the leading players, the competitive landscape of the at-home blood collection devices market to analyze market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. To estimate the market size of segments and subsegments, the market breakdown and data triangulation were used.

The four steps involved in estimating the market size are

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information as well as assess prospects.

The following is a breakdown of the primary respondents:

Breakdown Of Primary Participants:

At-home blood collection Devices Market Size, and Share

Note 1: Others include sales managers, marketing managers, and product managers.

Note 2: Companies are classified into tiers based on their total revenues. As of 2023, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = <USD 10 million.

To know about the assumptions considered for the study, download the pdf brochure

COMPANY NAME

DESIGNATION

YourBio Health

Sales Executive

Capitainer

Sales Executive

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the at-home blood collection devices market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry have been identified through extensive secondary research
  • The revenues generated by leading players operating in the at-home blood collection devices market have been determined through primary and secondary research.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Global At-home blood collection Devices Market Size: Bottom Up Approach

At-home blood collection Devices Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Data Triangulation

After arriving at the overall market size by applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

At-home blood collection devices are tools designed to allow individuals or professionals to collect small blood samples from home care settings. These devices are easy to use and minimally invasive, making them suitable for various applications.

Key Stakeholders

  • Senior Management
  • End User
  • R&D Department

Report Objectives

  • To define, describe, segment, and forecast the at-home blood collection devices market, by product, sample type, collection method, device type, usability, application, and region
  • To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
  • To analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the market segments in six regions: North America, Europe, the Asia Pacific, Middle East & Africa, Latin America, and GCC countries
  • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
  • To track and analyze company developments such as acquisitions, collaborations, partnerships, agreements, and product launches & approvals in the at-home blood collection devices market
  • To benchmark players within the at-home blood collection devices market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings

Available Customizations

MarketsandMarkets offers the following customizations for this market report.

Country Information

  • Additional country-level analysis of the at-home blood collection devices market

Company profiles

  • Additional five company profiles of players operating in the at-home blood collection devices market.

Product Analysis

  • Product matrix, which provides a detailed comparison of the product portfolio of each company in the at-home blood collection devices market

Get the Full Microsampling Devices Market Report

Full forecast, segment splits, and company analysis for all Microsampling Devices Market.

Need a Tailored Report?

Customize this report to your needs

Get 10% FREE Customization

Customize This Report
Fact checked
DMCA.com Protection Status